Glickman Richard M 4
4 · ESSA Pharma Inc. · Filed Apr 25, 2024
Insider Transaction Report
Form 4
ESSA Pharma Inc.EPIX
Glickman Richard M
Director
Transactions
- Exercise/Conversion
Common Shares
2024-04-24$4.90/sh+3,750$18,375→ 43,240 total - Exercise/Conversion
Options
2024-04-24−3,750→ 0 totalExercise: $4.90From: 2022-03-21Exp: 2024-05-21→ Common Shares (3,750 underlying)